Literature DB >> 20719939

Modulation of hepatic cytochrome P450s by Citrobacter rodentium infection in interleukin-6- and interferon-{gamma}-null mice.

Beatrice A Nyagode1, Choon-Myung Lee, Edward T Morgan.   

Abstract

After infection with Citrobacter rodentium, murine hepatic cytochrome P450 (P450) mRNAs are selectively regulated. Several serum proinflammatory cytokines are elevated, the most abundant being interleukin-6 (IL6). To elucidate the role of cytokines in the regulation of P450s during infection, we orally infected wild-type, IL6(-/-), or interferon-γ(-/-) [IFNγ(-/-)] female C57BL/6J mice with C. rodentium and analyzed hepatic P450 expression 7 days later. The majority of P450 mRNAs were equally affected by infection in each genotype, indicating that IL6 and IFNγ are not the primary mediators of P450 down-regulation in this disease model. The down-regulation of CYP3A11 and CYP3A13 and induction of CYP2D9 mRNAs were attenuated in the IL6(-/-) mice, suggesting a role of IL6 in the regulation of only these P450s. Similar evidence implicated IFNγ in the regulation of CYP2D9, CYP2D22, CYP3A11, CYP3A25, and CYP4F18 mRNAs in C. rodentium infection and CYP2B9, CYP2D22, and CYP2E1 in the bacterial lipopolysaccharide model of inflammation. This is the first indication of an in vivo role for IFNγ in hepatic P450 regulation in disease states. The deficiency of IL6 or IFNγ affected serum levels of the other cytokines. Moreover, experiments in cultured hepatocytes demonstrated that tumor necrosis factor α (TNFα) is the most potent and efficacious of the cytokines tested in the regulation of murine P450 expression. It is therefore possible that part of the IFNγ(-/-) and IL6(-/-) phenotypes could be attributed to the reduced levels of TNFα and part of the IFNγ(-/-) phenotype could be caused by reduced levels of IL6.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20719939      PMCID: PMC3202470          DOI: 10.1124/jpet.110.171488

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  37 in total

1.  Interferon gamma down-regulates cytochrome P450 3A genes in primary cultures of well-differentiated rat hepatocytes.

Authors:  M Tapner; C Liddle; B Goodwin; J George; G C Farrell
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

2.  Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1beta and endotoxin in primary rat hepatocytes.

Authors:  M B Sewer; E T Morgan
Journal:  Biochem Pharmacol       Date:  1997-09-15       Impact factor: 5.858

3.  Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes.

Authors:  M T Donato; M I Guillén; R Jover; J V Castell; M J Gómez-Lechón
Journal:  J Pharmacol Exp Ther       Date:  1997-04       Impact factor: 4.030

4.  Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.

Authors:  E Siewert; R Bort; R Kluge; P C Heinrich; J Castell; R Jover
Journal:  Hepatology       Date:  2000-07       Impact factor: 17.425

5.  Differential effects of cytokines on the inducible expression of CYP1A1, CYP1A2, and CYP3A4 in human hepatocytes in primary culture.

Authors:  J Muntané-Relat; J C Ourlin; J Domergue; P Maurel
Journal:  Hepatology       Date:  1995-10       Impact factor: 17.425

6.  Cytokines down-regulate expression of major cytochrome P-450 enzymes in adult human hepatocytes in primary culture.

Authors:  Z Abdel-Razzak; P Loyer; A Fautrel; J C Gautier; L Corcos; B Turlin; P Beaune; A Guillouzo
Journal:  Mol Pharmacol       Date:  1993-10       Impact factor: 4.436

7.  Immune response in mice that lack the interferon-gamma receptor.

Authors:  S Huang; W Hendriks; A Althage; S Hemmi; H Bluethmann; R Kamijo; J Vilcek; R M Zinkernagel; M Aguet
Journal:  Science       Date:  1993-03-19       Impact factor: 47.728

8.  Impaired immune and acute-phase responses in interleukin-6-deficient mice.

Authors:  M Kopf; H Baumann; G Freer; M Freudenberg; M Lamers; T Kishimoto; R Zinkernagel; H Bluethmann; G Köhler
Journal:  Nature       Date:  1994-03-24       Impact factor: 49.962

9.  Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver.

Authors:  E T Morgan; K B Thomas; R Swanson; T Vales; J Hwang; K Wright
Journal:  Biochim Biophys Acta       Date:  1994-10-18

10.  Suppression of the constitutive expression of cytochrome P-450 2C11 by cytokines and interferons in primary cultures of rat hepatocytes: comparison with induction of acute-phase genes and demonstration that CYP2C11 promoter sequences are involved in the suppressive response to interleukins 1 and 6.

Authors:  J Q Chen; A Ström; J A Gustafsson; E T Morgan
Journal:  Mol Pharmacol       Date:  1995-05       Impact factor: 4.436

View more
  11 in total

1.  Selective role for tumor necrosis factor-α, but not interleukin-1 or Kupffer cells, in down-regulation of CYP3A11 and CYP3A25 in livers of mice infected with a noninvasive intestinal pathogen.

Authors:  Ryan D Kinloch; Choon-Myung Lee; Nico van Rooijen; Edward T Morgan
Journal:  Biochem Pharmacol       Date:  2011-05-06       Impact factor: 5.858

2.  Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.

Authors:  Beatrice A Nyagode; Ifor R Williams; Edward T Morgan
Journal:  Inflammation       Date:  2014-06       Impact factor: 4.092

3.  Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1.

Authors:  Mark D DeBoer; Vidhya Vijayakumar; Meiqing Gong; John L Fowlkes; Rachel M Smith; Fernando Ruiz-Perez; James P Nataro
Journal:  Nutr Res       Date:  2017-02-07       Impact factor: 3.315

4.  CCN1 expression in hepatocytes contributes to macrophage infiltration in nonalcoholic fatty liver disease in mice.

Authors:  Zhaolian Bian; Yanshen Peng; Zhengrui You; Qixia Wang; Qi Miao; Yuan Liu; Xiaofeng Han; Dekai Qiu; Zhiping Li; Xiong Ma
Journal:  J Lipid Res       Date:  2012-10-15       Impact factor: 5.922

5.  Selective modulation of hepatic cytochrome P450 and flavin monooxygenase 3 expression during citrobacter rodentium infection in severe combined immune-deficient mice.

Authors:  Beatrice A Nyagode; William J Watkins; Ryan D Kinloch; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2012-06-27       Impact factor: 3.922

6.  Hepatic cytochrome P450s, phase II enzymes and nuclear receptors are downregulated in a Th2 environment during Schistosoma mansoni infection.

Authors:  Sylvie M Mimche; Beatrice A Nyagode; Matthew D Merrell; Choon-Myung Lee; Nina S Prasanphanich; Richard D Cummings; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-10-25       Impact factor: 3.922

7.  Selective and cytokine-dependent regulation of hepatic transporters and bile acid homeostasis during infectious colitis in mice.

Authors:  Matthew D Merrell; Beatrice A Nyagode; John D Clarke; Nathan J Cherrington; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2013-12-30       Impact factor: 3.922

8.  Selective effects of a therapeutic protein targeting tumor necrosis factor-alpha on cytochrome P450 regulation during infectious colitis: Implications for disease-dependent drug-drug interactions.

Authors:  Beatrice A Nyagode; Roya Jahangardi; Matthew D Merrell; Malú G Tansey; Edward T Morgan
Journal:  Pharmacol Res Perspect       Date:  2014-02-01

9.  Cytochrome P450-mediated drug interactions in COVID-19 patients: Current findings and possible mechanisms.

Authors:  Mahmoud A El-Ghiaty; Sherif M Shoieb; Ayman O S El-Kadi
Journal:  Med Hypotheses       Date:  2020-06-26       Impact factor: 1.538

Review 10.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.